论文部分内容阅读
在幼儿中b型流感杆菌感染是一个严重的问题,目前加拿大使用的b型流感杆菌荚膜多糖与白喉类毒素(PRP/D)混合制剂已被批准用于18月龄儿童,由于此年龄需作DTP加强接种,因此必须在不同部位接受2次肌肉注射。作者提出将DTP与PRP/D联合1次肌肉注射;并同时用DTP与PRP/D分开接种作为对照,同时又分别接种于手臂和股部内侧,以比较其全身与局部反应性。
Influenza b infection is a serious problem in young children. At present, the combination of influenza b-type b capsular polysaccharide and diphtheria toxoid (PRP / D) used in Canada has been approved for 18-month-old children. For DTP vaccination, it is necessary to accept 2 different intramuscular injection. The authors proposed a single intramuscular injection of DTP in combination with PRP / D, while DTP and PRP / D were inoculated separately as controls, while inoculated separately into the medial arm and femoral component to compare their systemic and local reactivity.